51 related articles for article (PubMed ID: 8871647)
1. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules.
Sidney J; Southwood S; del Guercio MF; Grey HM; Chesnut RW; Kubo RT; Sette A
J Immunol; 1996 Oct; 157(8):3480-90. PubMed ID: 8871647
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of predicted HLA binding peptides of JE viral proteins specific to north Indian isolates.
Sharma P; Saxena K; Mishra S; Kumar A
Bioinformation; 2014; 10(6):334-41. PubMed ID: 25097375
[TBL] [Abstract][Full Text] [Related]
3. High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies.
Çınar Ö; Brzezicha B; Grunert C; Kloetzel PM; Beier C; Peuker CA; Keller U; Pezzutto A; Busse A
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330762
[TBL] [Abstract][Full Text] [Related]
4. Epitope prediction and identification- adaptive T cell responses in humans.
Sidney J; Peters B; Sette A
Semin Immunol; 2020 Aug; 50():101418. PubMed ID: 33131981
[TBL] [Abstract][Full Text] [Related]
5. A Review on T Cell Epitopes Identified Using Prediction and Cell-Mediated Immune Models for
Tian Y; da Silva Antunes R; Sidney J; Lindestam Arlehamn CS; Grifoni A; Dhanda SK; Paul S; Peters B; Weiskopf D; Sette A
Front Immunol; 2018; 9():2778. PubMed ID: 30555469
[TBL] [Abstract][Full Text] [Related]
6. A general strategy to optimize immunogenicity of HLA-B*0702 restricted cryptic peptides from tumor associated antigens: Design of universal neo-antigen like tumor vaccines for HLA-B*0702 positive patients.
Gallou C; Rougeot A; Graff-Dubois S; Kosmatopoulos K; Menez-Jamet J
Oncotarget; 2016 Sep; 7(37):59417-59428. PubMed ID: 27506946
[TBL] [Abstract][Full Text] [Related]
7. Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP).
Sedegah M; Kim Y; Ganeshan H; Huang J; Belmonte M; Abot E; Banania JG; Farooq F; McGrath S; Peters B; Sette A; Soisson L; Diggs C; Doolan DL; Tamminga C; Villasante E; Hollingdale MR; Richie TL
Malar J; 2013 Jun; 12():185. PubMed ID: 23738590
[TBL] [Abstract][Full Text] [Related]
8. Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.
Sidney J; Southwood S; Moore C; Oseroff C; Pinilla C; Grey HM; Sette A
Curr Protoc Immunol; 2013 Feb; Chapter 18():Unit 18.3.. PubMed ID: 23392640
[TBL] [Abstract][Full Text] [Related]
9. Identification of three novel CTL epitopes within nucleocapsid protein of Hantaan virus.
Wang M; Zhu Y; Wang J; Lv T; Jin B
Viral Immunol; 2011 Dec; 24(6):449-54. PubMed ID: 22111596
[TBL] [Abstract][Full Text] [Related]
10. The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection.
Reed JS; Sidney J; Piaskowski SM; Glidden CE; León EJ; Burwitz BJ; Kolar HL; Eernisse CM; Furlott JR; Maness NJ; Walsh AD; Rudersdorf RA; Bardet W; McMurtrey CP; O'Connor DH; Hildebrand WH; Sette A; Watkins DI; Wilson NA
Immunogenetics; 2011 Dec; 63(12):789-807. PubMed ID: 21732180
[TBL] [Abstract][Full Text] [Related]
11. HLA class I allele promiscuity revisited.
Rao X; Hoof I; Costa AI; van Baarle D; Keşmir C
Immunogenetics; 2011 Nov; 63(11):691-701. PubMed ID: 21695550
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1*02601 and Mamu-B*08301 reveals HLA-A2 and HLA-A3 supertypic specificities.
Southwood S; Solomon C; Hoof I; Rudersdorf R; Sidney J; Peters B; Wahl A; Hawkins O; Hildebrand W; Mothé BR; Sette A
Immunogenetics; 2011 May; 63(5):275-90. PubMed ID: 21274527
[TBL] [Abstract][Full Text] [Related]
13. The most common Chinese rhesus macaque MHC class I molecule shares peptide binding repertoire with the HLA-B7 supertype.
Solomon C; Southwood S; Hoof I; Rudersdorf R; Peters B; Sidney J; Pinilla C; Marcondes MC; Ling B; Marx P; Sette A; Mothé BR
Immunogenetics; 2010 Jul; 62(7):451-64. PubMed ID: 20480161
[TBL] [Abstract][Full Text] [Related]
14. Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development.
Johnson KL; Ovsyannikova IG; Mason CJ; Bergen HR; Poland GA
Vaccine; 2009 Dec; 28(1):38-47. PubMed ID: 19822231
[TBL] [Abstract][Full Text] [Related]
15. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries.
Sidney J; Assarsson E; Moore C; Ngo S; Pinilla C; Sette A; Peters B
Immunome Res; 2008 Jan; 4():2. PubMed ID: 18221540
[TBL] [Abstract][Full Text] [Related]
16. HLA class I supertypes: a revised and updated classification.
Sidney J; Peters B; Frahm N; Brander C; Sette A
BMC Immunol; 2008 Jan; 9():1. PubMed ID: 18211710
[TBL] [Abstract][Full Text] [Related]
17. Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.
Depla E; Van der Aa A; Livingston BD; Crimi C; Allosery K; De Brabandere V; Krakover J; Murthy S; Huang M; Power S; Babé L; Dahlberg C; McKinney D; Sette A; Southwood S; Philip R; Newman MJ; Meheus L
J Virol; 2008 Jan; 82(1):435-50. PubMed ID: 17942551
[TBL] [Abstract][Full Text] [Related]
18. SVMHC: a server for prediction of MHC-binding peptides.
Dönnes P; Kohlbacher O
Nucleic Acids Res; 2006 Jul; 34(Web Server issue):W194-7. PubMed ID: 16844990
[TBL] [Abstract][Full Text] [Related]
19. Detailed characterization of the peptide binding specificity of five common Patr class I MHC molecules.
Sidney J; Asabe S; Peters B; Purton KA; Chung J; Pencille TJ; Purcell R; Walker CM; Chisari FV; Sette A
Immunogenetics; 2006 Jul; 58(7):559-70. PubMed ID: 16791621
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
